Literature DB >> 21293504

Pancreatic cancer in 2010: new insights for early intervention and detection.

Eithne Costello1, John P Neoptolemos.   

Abstract

Pancreatic cancer is usually detected at an advanced stage and responds poorly to treatment. In 2010 new insights were gained into understanding the complex biology of pancreatic cancer. Importantly, these insights offer novel opportunities for early diagnosis and treatment of this disease.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21293504     DOI： 10.1038/nrgastro.2010.214

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  10 in total

1.  New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.

Authors:  Donghui Li; James L Abbruzzese
Journal:  Clin Cancer Res       Date:  2010-07-20       Impact factor: 12.531

2.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer.

Authors:  Peter J Campbell; Shinichi Yachida; Laura J Mudie; Philip J Stephens; Erin D Pleasance; Lucy A Stebbings; Laura A Morsberger; Calli Latimer; Stuart McLaren; Meng-Lay Lin; David J McBride; Ignacio Varela; Serena A Nik-Zainal; Catherine Leroy; Mingming Jia; Andrew Menzies; Adam P Butler; Jon W Teague; Constance A Griffin; John Burton; Harold Swerdlow; Michael A Quail; Michael R Stratton; Christine Iacobuzio-Donahue; P Andrew Futreal
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

3.  Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels.

Authors:  Ang Li; Noriyuki Omura; Seung-Mo Hong; Audrey Vincent; Kimberly Walter; Margaret Griffith; Michael Borges; Michael Goggins
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

4.  Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Authors:  John P Neoptolemos; Deborah D Stocken; Claudio Bassi; Paula Ghaneh; David Cunningham; David Goldstein; Robert Padbury; Malcolm J Moore; Steven Gallinger; Christophe Mariette; Moritz N Wente; Jakob R Izbicki; Helmut Friess; Markus M Lerch; Christos Dervenis; Attila Oláh; Giovanni Butturini; Ryuichiro Doi; Pehr A Lind; David Smith; Juan W Valle; Daniel H Palmer; John A Buckels; Joyce Thompson; Colin J McKay; Charlotte L Rawcliffe; Markus W Büchler
Journal:  JAMA       Date:  2010-09-08       Impact factor: 56.272

5.  Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.

Authors:  Jin-Hyeok Hwang; Johannes Voortman; Elisa Giovannetti; Seth M Steinberg; Leticia G Leon; Yong-Tae Kim; Niccola Funel; Joo Kyung Park; Min A Kim; Gyeong Hoon Kang; Sun-Whe Kim; Marco Del Chiaro; Godefridus J Peters; Giuseppe Giaccone
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

6.  Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.

Authors:  Christoph Schröder; Anette Jacob; Sarah Tonack; Tomasz P Radon; Martin Sill; Manuela Zucknick; Sven Rüffer; Eithne Costello; John P Neoptolemos; Tatjana Crnogorac-Jurcevic; Andrea Bauer; Kurt Fellenberg; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2010-02-16       Impact factor: 5.911

7.  Genome-wide association study of pancreatic cancer in Japanese population.

Authors:  Siew-Kee Low; Aya Kuchiba; Hitoshi Zembutsu; Akira Saito; Atsushi Takahashi; Michiaki Kubo; Yataro Daigo; Naoyuki Kamatani; Suenori Chiku; Hirohiko Totsuka; Sumiko Ohnami; Hiroshi Hirose; Kazuaki Shimada; Takuji Okusaka; Teruhiko Yoshida; Yusuke Nakamura; Hiromi Sakamoto
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

8.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Authors:  John P Morris; David A Cano; Shigeki Sekine; Sam C Wang; Matthias Hebrok
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

9.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Authors:  Gloria M Petersen; Laufey Amundadottir; Charles S Fuchs; Peter Kraft; Rachael Z Stolzenberg-Solomon; Kevin B Jacobs; Alan A Arslan; H Bas Bueno-de-Mesquita; Steven Gallinger; Myron Gross; Kathy Helzlsouer; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Harvey A Risch; Wei Zheng; Demetrius Albanes; William R Bamlet; Christine D Berg; Marie-Christine Boutron-Ruault; Julie E Buring; Paige M Bracci; Federico Canzian; Sandra Clipp; Michelle Cotterchio; Mariza de Andrade; Eric J Duell; J Michael Gaziano; Edward L Giovannucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Manal Hassan; Barbara Howard; David J Hunter; Amy Hutchinson; Mazda Jenab; Rudolf Kaaks; Charles Kooperberg; Vittorio Krogh; Robert C Kurtz; Shannon M Lynch; Robert R McWilliams; Julie B Mendelsohn; Dominique S Michaud; Hemang Parikh; Alpa V Patel; Petra H M Peeters; Aleksandar Rajkovic; Elio Riboli; Laudina Rodriguez; Daniela Seminara; Xiao-Ou Shu; Gilles Thomas; Anne Tjønneland; Geoffrey S Tobias; Dimitrios Trichopoulos; Stephen K Van Den Eeden; Jarmo Virtamo; Jean Wactawski-Wende; Zhaoming Wang; Brian M Wolpin; Herbert Yu; Kai Yu; Anne Zeleniuch-Jacquotte; Joseph F Fraumeni; Robert N Hoover; Patricia Hartge; Stephen J Chanock
Journal:  Nat Genet       Date:  2010-01-24       Impact factor: 38.330

10.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962
  10 in total
  19 in total

1.  Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.

Authors:  Luo-Wei Wang; Zheng Huang; Han Lin; Zhao-Shen Li; Fred Hetzel; Bolin Liu Md
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-01-30       Impact factor: 3.631

2.  IRF-2 is over-expressed in pancreatic cancer and promotes the growth of pancreatic cancer cells.

Authors:  Lei Cui; Yuezhen Deng; Yefei Rong; Wenhui Lou; Zhengfa Mao; Yuanyuan Feng; Dong Xie; Dayong Jin
Journal:  Tumour Biol       Date:  2011-11-26

3.  Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.

Authors:  M Li; Z W Zhao
Journal:  Med Oncol       Date:  2011-06-10       Impact factor: 3.064

4.  Organ Specific Tumor Markers: What's New?

Authors:  Kannan Vaidyanathan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2011-11-08

5.  Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K.

Authors:  Cheng Fang; Xin Guo; Xing Lv; Ruozhe Yin; Xiaohui Lv; Fengsong Wang; Jun Zhao; Quan Bai; Xuebiao Yao; Yong Chen
Journal:  J Mol Cell Biol       Date:  2017-12-01       Impact factor: 6.216

6.  MicroRNA-221 induces autophagy through suppressing HDAC6 expression and promoting apoptosis in pancreatic cancer.

Authors:  Yifan Yang; Yang Sun; Huaitao Wang; Hansi Li; Mingjie Zhang; Lei Zhou; Xiangli Meng; Yunhao Wu; Peng Liu; Xin Liu; Jun Zhang; Xiaodong Tan
Journal:  Oncol Lett       Date:  2018-09-27       Impact factor: 2.967

7.  The Antipancreatic Cancer Activity of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2.

Authors:  Bo Chen; Ming Xu; Hui Zhang; Ming-zheng Xu; Xu-jing Wang; Qing-he Tang; Jian-ying Tang
Journal:  DNA Cell Biol       Date:  2015-08-18       Impact factor: 3.311

8.  The mitochondrion interfering compound NPC-26 exerts potent anti-pancreatic cancer cell activity in vitro and in vivo.

Authors:  Yang-Yang Dong; Yi-Huang Zhuang; Wen-Jie Cai; Yan Liu; Wen-Bing Zou
Journal:  Tumour Biol       Date:  2016-09-22

Review 9.  Pancreatic cancer chemoprevention by phytochemicals.

Authors:  Srinivas Reddy Boreddy; Sanjay K Srivastava
Journal:  Cancer Lett       Date:  2012-10-27       Impact factor: 8.679

10.  Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel.

Authors:  Yong-Jian Jiang; Chong-Lek Lee; Qiang Wang; Zhong-Wen Zhou; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.